t-all diagnosis: cytogenetics, genomics and risk assessment
Published 3 years ago • 166 plays • Length 4:31Download video MP4
Download video MP3
Similar videos
-
1:17
diagnosing rt and identifying patients at risk using ngs and molecular cytogenetic analysis
-
1:25
the diagnosis of early t-cell precursor (etp) all
-
1:32
the importance of cytogenetics and molecular profiling for accurate aml/mds diagnosis
-
2:57
genome characterization of t-all patients
-
1:41
the importance of integrating genomic and cytogenetic data in treatment decisions for aml
-
10:19
early t-cell precursor lymphoblastic leukemia (etp-all)
-
28:19
diagnosis: morphology, flow cytometry, cytogenetics, molecular testing, and risk-stratification
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
1:33
all diagnostics: challenges and considerations
-
1:52
aml: the cytogenetic risk score
-
1:44
treatment options for patients with early t-cell precursor all
-
8:57
outcomes of sct in t-all and t-lbl
-
2:04
the impact of cytogenetics on treatment decisions in aml
-
0:48
building genetic assessments into how we determine prognosis of all
-
1:45
impact of cytogenetic abnormalities on os following sct in pediatric aml
-
1:40
mutations in all and their implications for treatment decisions
-
1:17
the all frontier: should t-all be classed as a different disease?
-
2:42
the biology of t-all
-
2:15
management of adult t-all
-
3:16
the management of high-risk all
-
1:22
understanding the rpl10 r98s mutation in t-all
-
2:57
the importance of analyzing cytogenetic risk in patients with aml undergoing haploidentical sct